- Reported purity
- No purity printed
- Test date
- Sep 26, 2026
- Laboratory named
- Chromate
Lot details
TZ05
Loading peptide prices…
Loading peptide prices…
Compare observed vial prices, price per mg, and current indexed COA records across vendors.
Indexed documents do not establish product quality. Missing means we have not indexed one. Index as of Oct 2026.
Price-drop alert
Today’s lowest in-stock price is $2.40/mg. We check daily and email you once if it drops 10% or more. The alert ends after that, or after six months.
Some outbound vendor links are affiliate links. Commission status does not change the displayed prices, indexed COA fields, or certificate filters.
Observed market data
Document coverage, not product quality.
Observed Tirzepatide listings span $15-$1800 in total vial price, with a median of $4.69 per mg across 460 usable listings as of Oct 5, 2026. Compare Tirzepatide by vial size, total price, price per mg, stock signal, vendor coverage, and last-checked date. These market observations do not verify product quality or recommend a seller. Each vendor row shows its current COA record, including the reported purity, named lab, and printed test date.
Observed Tirzepatide listings span $15-$1800 in total vial price, with a median of $4.69 per mg across 460 usable listings as of Oct 5, 2026.
The comparison covers observed vial prices, price per mg, vial sizes, stock signals, vendor coverage, and last-checked dates. It does not verify product quality or recommend a seller.
The index has a current certificate on file for 34 of 152 tracked Tirzepatide vendors, with 165 public documents. Vendors may have testing that we have not indexed.
Choose “Highest COA purity” to sort vendors by the value printed on each current certificate. The number belongs to that document, lab, lot, and test date. It cannot establish product quality or safety, and values from different labs or methods are not directly comparable.
Product documentation
Current certificates are on file for 34 of 152 tracked vendors. The public evidence set contains 165 documents naming 11 laboratories. Reported test dates in this set run from Feb 23, 2024 through Sep 26, 2026.
118 tracked vendors have no current certificate in this index. Those vendors may have testing we have not indexed.
34 current records
TZ05
TRZ60-05
NL03-NL2T10
GLP-230-MH-03
TZ2608
SYN-070126
IP-2607-127
00256
B002B
05-05260628
DRL-08-2708
PUR2T30004
TIXH0062661
20261075
LSSTZ3002 (Vial 2)
ION2T10-05122026
P2L-T30-19 / P1L-T30-19
11244-SG5
BX-P-C3R6
TS-0429-GLP2-A
C51T2W
WLTZ-20-10002
T102026
EP-250605-TZ10
FP25-0101
LOT-TIRZ-00002
TZ10/2025-03
011425FF
2024-07-12
2024-02-12
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
Lab, lot, date, compound, and purity fields are transcribed from the document and can contain extraction errors. “Older record” means the reported test date is more than 18 months old.
Learn how to read a peptide COA or review the testing methodology and dataset.
The clinic network
Request a free connection to a peptide clinic, by telehealth or in person. A licensed clinician decides whether any treatment is right for you. What peptide therapy involves